Search Main Menu Main Content
  • Change contrast :
Haute Autorité de Santé
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Recherche
  • icone plus

  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

  • No element in selection

  • Contact

1 result

  • Topics : Infectious diseases
  • Topics : Eye diseases
  • Topics : Diagnostic and therapeutic techniques
  • Active substance : doxycycline
  • Active substance : albendazole
Filter
Topic
  • Diagnostic and therapeutic techniques (1)
  • Plus ...
    • Diagnostic techniques and procedures (1)
    • Plus ...
      • Biology (laboratory tests) (1)
  • Diseases and conditions (1)
  • Plus ...
    • Eye diseases (1)
    • Infectious diseases (1)
    • Plus ...
      • Parasitic diseases and mycoses (1)
    • Blood and lymphatic diseases (1)
    • Plus ...
      • Lymphatic diseases (1)
    • Skin and connective tissue diseases (1)
Content type
  • Drugs, devices and medical acts (1)
  • Plus ...
    • Health technology assessment (1)
Date
  • Last five years (1)
Language
  • Français (1)
Active substance
  • albendazole (1)
  • alcool (1)
  • doxycycline (1)
  • ivermectine (1)

Drugs, devices and medical acts - 1 result

  • Update of the Nomenclature of Laboratory Medicine Procedures for the diagnosis and monitoring of filariasis - INAHTA Brief

    Health technology assessment - Posted on 16/4/2018
    Download document
    Add to my selection
Haute Autorité de Santé
Advancing quality in the fields of health and social care services

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • fr Français
  • en English
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
6WT3RBcWdPrqU0Km